Cibus (CBUS) awards CSO 57K shares and 114K stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Gocal Gregory Francis William reported acquisition or exercise transactions in this Form 4 filing.
Cibus, Inc. reported that Chief Scientific Officer & EVP Gregory Francis William Gocal received equity awards on April 24, 2026. He was granted 57,000 shares of Class A common stock and 114,000 stock options to buy Class A common at $1.50 per share.
Following the grant, he directly holds 422,890 common shares and 114,000 options. According to the vesting terms, 1/48th of the options vest monthly on the 24th of each month until the fourth anniversary of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Gocal Gregory Francis William
Role
Chief Scientific Officer & EVP
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right-to-Buy) | 114,000 | $0.00 | -- |
| Grant/Award | Class A Common Stock | 57,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right-to-Buy) — 114,000 shares (Direct, null);
Class A Common Stock — 422,890 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Common shares granted: 57,000 shares
Options granted: 114,000 options
Option exercise price: $1.50 per share
+3 more
6 metrics
Common shares granted
57,000 shares
Class A Common Stock grant on April 24, 2026
Options granted
114,000 options
Stock Option (Right-to-Buy) grant on April 24, 2026
Option exercise price
$1.50 per share
Conversion or exercise price for stock options
Shares held after grant
422,890 shares
Total Class A Common Stock directly owned post-transaction
Options held after grant
114,000 options
Total stock options directly owned post-transaction
Option expiration date
April 24, 2036
Expiration of Stock Option (Right-to-Buy)
Key Terms
Stock Option (Right-to-Buy), Class A Common Stock, conversion or exercise price, vesting, +1 more
5 terms
Stock Option (Right-to-Buy) financial
"security_title: "Stock Option (Right-to-Buy)""
Class A Common Stock financial
"security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
conversion or exercise price financial
"conversion_or_exercise_price: "1.5000""
vesting financial
"1/48th of the total options vest monthly on the 24th"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
What equity awards did Cibus (CBUS) grant to its Chief Scientific Officer?
Cibus granted its Chief Scientific Officer Gregory Francis William Gocal 57,000 Class A common shares and 114,000 stock options. The options allow him to buy Class A common stock at a $1.50 exercise price under a multi-year vesting schedule.
What is the exercise price and term of the new Cibus (CBUS) stock options?
The new stock options granted to Gregory Gocal have a $1.50 per share exercise price and expire on April 24, 2036. They are tied to 114,000 underlying Class A common shares, giving him long-dated potential ownership if exercised.
How do the Cibus (CBUS) options granted to the CSO vest over time?
The options vest gradually, with 1/48th of the total vesting each month on the 24th. This schedule continues until the fourth anniversary of the April 24, 2026 grant date, aligning vesting with longer-term service at the company.
Are the Cibus (CBUS) equity awards to the CSO open-market purchases or compensation grants?
The awards are compensation-related grants, not open-market purchases. The Form 4 lists transaction code A, described as a grant, award, or other acquisition, with a $0.00 transaction price for both the common shares and the stock options.